clofibric acid has been researched along with omeprazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tielemans, YK; Willems, GE | 1 |
| Hammer, TA; Sandvik, AK; Waldum, HL | 1 |
| Bendheim, MØ; Martinsen, TC; Skogaker, NE; Waldum, HL | 1 |
1 review(s) available for clofibric acid and omeprazole
| Article | Year |
|---|---|
[Growth factors of enterochromaffin-like cells and physiopathology of experimental carcinoid tumors].
Topics: Animals; Clofibric Acid; Enterochromaffin Cells; Female; Fibric Acids; Gastric Mucosa; Gastrins; Growth Substances; Hypolipidemic Agents; Male; Neoplasms, Experimental; Omeprazole; Portacaval Shunt, Surgical; Rats; Somatostatin; Stomach Neoplasms | 1991 |
2 other study(ies) available for clofibric acid and omeprazole
| Article | Year |
|---|---|
Potentiating hypergastrinemic effect by the peroxisome proliferator ciprofibrate and omeprazole in the rat.
Topics: Animals; Anti-Ulcer Agents; Clofibric Acid; Drug Interactions; Enterochromaffin-like Cells; Female; Fibric Acids; Gastric Mucosa; Gastrins; Hypolipidemic Agents; Microbodies; Omeprazole; Rats; RNA, Messenger; Somatostatin | 1998 |
Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Clofibric Acid; Fibric Acids; Gastrin-Secreting Cells; Gastrins; Immunohistochemistry; Male; Microscopy, Immunoelectron; Omeprazole; Pantoprazole; Peroxisome Proliferators; Peroxisomes; Proton Pump Inhibitors; Pyloric Antrum; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Sulfoxides; Transcription Factors | 2003 |